Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

NCT00601900 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

394

Enrollment

NIH

Sponsor class

Conditions

Invasive Breast Carcinoma
Recurrent Breast Carcinoma
Stage III Breast Cancer AJCC v6
Stage IV Breast Cancer AJCC v6 and v7

Interventions

BIOLOGICAL: Bevacizumab
OTHER: Laboratory Biomarker Analysis
DRUG: Letrozole
OTHER: Questionnaire Administration
DRUG: Tamoxifen Citrate

Sponsor

National Cancer Institute (NCI)